1. Home
  2. LND vs CABA Comparison

LND vs CABA Comparison

Compare LND & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

LND

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

N/A

Current Price

$3.21

Market Cap

357.6M

ML Signal

N/A

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

N/A

Current Price

$1.41

Market Cap

339.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LND
CABA
Founded
2005
2017
Country
Brazil
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
357.6M
339.1M
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
LND
CABA
Price
$3.21
$1.41
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $13.25
AVG Volume (30 Days)
66.0K
★ 4.8M
Earning Date
11-03-2026
11-13-2026
Dividend Yield
★ 1.27%
N/A
EPS Growth
N/A
★ 10.26
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$48.42
N/A
Revenue Next Year
$6.82
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.12
$1.32
52 Week High
$4.45
$4.23

Technical Indicators

Market Signals
Indicator
LND
CABA
Relative Strength Index (RSI) 31.74 33.69
Support Level N/A N/A
Resistance Level $3.81 $2.14
Average True Range (ATR) 0.11 0.14
MACD -0.05 0.03
Stochastic Oscillator 14.77 25.00

Price Performance

Historical Comparison
LND
CABA

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.

Share on Social Networks: